Table 3. Clinical and biological characteristics of the cohort upon 18FDG PET/CT use.
| n | Age | Gender | Dialysis | KTR | eGFR | WBC | CRP | Germ ID | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Urine | Blood | |||||||||
| (years) | (male, %) | (%) | (%) | (ml/min) | (106/mm³) | (mg/L) | (+, %) | (+, %) | ||
| 18FDG PET/CT | 28 | 56 ± 11 | 57 | 14 | 71 | 40 ± 17 | 10.2 ± 3.7 | 127 ± 125 | 28 | 28 |
| cyst infection | 10 | 52 ± 11 | 70 | 20 | 50 | 36 ± 15 | 10.2 ± 2.4 | 207 ± 120 | 10 | 30 |
| non-cystic diseases | 5 | 60 ± 10 | 60 | 0 | 100 | 40 ± 23 | 10.5 ± 2.6 | 38 ± 12 | 60 | 40 |
| no 18FDG uptake | 13 | 56 ± 11 | 46 | 15 | 77 | 44 ± 17 | 10.1 ± 4.9 | 99 ± 121 | 31 | 23 |
| No 18FDG PET/CT | 60 | 49 ± 15 | 50 | 5 | 31 | 67 ± 45 | 11.1 ± 4.7 | 89 ± 125 | 28 | 18 |
| excl. cyst hemorrhage | 31 | 53 ± 17 | 42 | 10 | 48 | 50 ± 38 | 12.4 ± 5.5 | 157 ± 141 | 45 | 29 |
KTR, kidney transplant recipients; eGFR, estimated glomerular filtration rate; WBC, white blood cells at admission; CRP, C-reactive protein level at admission; ID, identification. Mean +/- Standard Deviation.